{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:15:35Z","timestamp":1760141735036,"version":"build-2065373602"},"reference-count":90,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Reports"],"abstract":"<jats:p>Background\/Objectives: This review article highlights the role of the nucleotide-binding domain, leucine-rich repeat, pyrin domain-containing 3 protein (NLRP3) inflammasomes in various gastrointestinal and hepatic disorders in the pediatric age group. NLRP3 inflammasomes are one of the principal intracellular innate immune sensors. During inflammation, molecules such as caspase-1 and the release of IL-1\u03b2 and IL-18 are produced. The NLRP3 inflammasome participates in the preservation of intestinal homeostasis and mucosal immune response. The objective is to evaluate the published articles related to the role of NLRP3 inflammasomes in common pediatric gastrointestinal and hepatic disorders in order to identify the future perspective regarding their possible therapeutic values. Methods: We searched Medline for NLRP3 inflammasomes and disorders of the digestive system during childhood. Results: Although the majority of articles were related to various disorders of adults, such as Alzheimer\u2019s disease, Parkinson\u2019s disease, atherosclerosis, as well as neurodevelopmental disorders, such as schizophrenia, a few published datasets were related to the roles of NLRP3 in the pediatric age group: they addressed autism, rheumatoid arthritis, and other autoimmune diseases, as well as inflammatory bowel diseases (IBD) and hepatic infection. Some research demonstrated that the NLRP3 inflammasome has a protective role; however, it also has a pathogenic function. Conclusions: This review focused on the comprehensive role of inflammasome NLRP3 in the most common pediatric and neonatal gastrointestinal and hepatic diseases, including clinical and experimental studies, as well as the pharmacological inhibitors for NLRP3 inflammasomes, which may provide future therapy for GIT problems, such as IBD.<\/jats:p>","DOI":"10.3390\/pediatric17050103","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T15:48:30Z","timestamp":1759852110000},"page":"103","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of NLRP3 Inflammasomes in Disorders of Children\u2019s Digestive Systems: A Narrative Review"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4853-4648","authenticated-orcid":false,"given":"Safaa","family":"ELMeneza","sequence":"first","affiliation":[{"name":"Faculty of Medicine for Girls, Al-Azhar University, Cairo 4434103, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Watanabe, D., Guo, Y., and Kamada, N. (2021). Interaction between the inflammasome and commensal microorganisms in gastrointestinal health and disease. EMBO Mol. Med., 13.","DOI":"10.15252\/emmm.202013452"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zahid, A., Li, B., Kombe, A.J.K., Jin, T., and Tao, J. (2019). Pharmacological Inhibitors of the NLRP3 Inflammasome. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02538"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Fields, J.K., G\u00fcnther, S., and Sundberg, E.J. (2019). Structural Basis of IL-1 Family Cytokine Signaling. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01412"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Hafner-Bratkovi\u010d, I., Su\u0161jan, P., Lain\u0161\u010dek, D., Tapia-Abell\u00e1n, A., Cerovi\u0107, K., Kadunc, L., Angosto-Bazarra, D., Pelegrin, P., and Jerala, R. (2018). NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway. Nat. Commun., 9.","DOI":"10.1038\/s41467-018-07573-4"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cytogfr.2021.03.003","article-title":"Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease","volume":"60","author":"Song","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and Regulation of NLRP3 Inflammasome Activation","volume":"4","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.cell.2017.01.008","article-title":"Snap Shot: The Noncanonical Inflammasome","volume":"168","author":"Ding","year":"2017","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kelley, N., Jeltema, D., Duan, Y., and He, Y. (2019). The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133328"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mi.2015.109","article-title":"Posttranscriptional control of NLRP3 inflammasome activation in colonic macrophages","volume":"9","author":"Filardy","year":"2016","journal-title":"Mucosal Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11882-010-0109-z","article-title":"Inflammasome and IL-1beta-mediated disorders","volume":"10","author":"Hoffman","year":"2010","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/NPM-210909","article-title":"The role of nod-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome in the diagnosis of late-onset neonatal sepsis","volume":"15","author":"Mohamed","year":"2022","journal-title":"J. Neonatal Perinat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clinre.2017.09.003","article-title":"Association of NLRP3 single nucleotide polymorphisms with ulcerative colitis: A case-control study","volume":"42","author":"Hanaei","year":"2018","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.3748\/wjg.v25.i33.4796","article-title":"Role of NLRP3 inflammasome in inflammatory bowel diseases","volume":"25","author":"Tourkochristou","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/eji.201444707","article-title":"Impaired NLRP3 inflammasome activity during fetal development regulates IL-1\u03b2 production in human monocytes","volume":"45","author":"Sharma","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Motomura, K., Romero, R., Galaz, G., Tao, L., Flores, V.G., Xu, Y., Done, B., Hernandez, M.A., Miller, D., and Contreras, P.G. (2022). Fetal and maternal NLRP3 signaling is required for preterm labor and birth. JCI Insight, 7.","DOI":"10.1172\/jci.insight.158238"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wackerbarth, L.M., Seifert, S.B., Napoli, M., Rohwedder, I., Vogl, T., Scheiermann, C., Kolben, T., Nussbaum, C., Pruenster, M., and Immler, R. (2025). Neonatal neutrophils exhibit reduced NLRP3 inflammasome activation. J. Leukoc. Biol., 117.","DOI":"10.1093\/jleuko\/qiae206"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3345\/cep.2024.01935","article-title":"NLRP3 inflammasome: A key player in neonatal brain injury","volume":"68","author":"Kiser","year":"2025","journal-title":"Clin. Exp. Pediatr."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Tarakcioglu, E., Genc, B., Tufekci, K.U., and Genc, S. (2025). Neonatal NLRP3 Inflammasome Activation Leads to Perineuronal Net Deficits in Early Adulthood. Dev. Neurobiol., 85.","DOI":"10.1002\/dneu.22986"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12519-023-00727-5","article-title":"NLRP3 activation in macrophages promotes acute intestinal injury in neonatal necrotizing enterocolitis","volume":"20","author":"Shi","year":"2024","journal-title":"World J. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Saavedra-Torres, J.S., Pinz\u00f3n-Fern\u00e1ndez, M.V., Ocampo-Posada, M., Nati-Castillo, H.A., Jim\u00e9nez Hincapie, L.A., Cadrazo-Gil, E.J., Arias-Intriago, M., Rojas-Cadena, M., Tello-De-la-Torre, A., and Osejos, W. (2025). Inflammasomes and Signaling Pathways: Key Mechanisms in the Pathophysiology of Sepsis. Cells, 14.","DOI":"10.3390\/cells14120930"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.5152\/TurkArchPediatr.2021.21108","article-title":"Role of Serum Apelin in the Diagnosis of Early-Onset Neonatal Sepsis","volume":"56","author":"ELMeneza","year":"2021","journal-title":"Turk. Arch. Pediatr."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Zhao, C., and Zhao, W. (2020). NLRP3 Inflammasome\u2014A Key Player in Antiviral Responses. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00211"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Pierantonelli, I., Rychlicki, C., Agostinelli, L., Giordano, D.M., Gaggini, M., Fraumene, C., Saponaro, C., Manghina, V., Sartini, L., and Mingarelli, E. (2017). Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-11744-6"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature18590","article-title":"Pore-forming activity and structural autoinhibition of the gasdermin family","volume":"535","author":"Ding","year":"2016","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chiang, H.Y., Lu, H.H., Sudhakar, J.N., Chen, Y.W., Shih, N.S., Weng, Y.T., and Shui, J.W. (2022). IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence. Nat. Commun., 13.","DOI":"10.1038\/s41467-022-28478-3"},{"key":"ref_27","first-page":"737","article-title":"The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans","volume":"11","author":"Liu","year":"2017","journal-title":"J. Crohns Colitis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1126\/science.aal3535","article-title":"Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages","volume":"356","author":"Ip","year":"2017","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2010.03.003","article-title":"The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis","volume":"32","author":"Zaki","year":"2010","journal-title":"Immunity"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.it.2011.02.002","article-title":"The Nlrp3 inflammasome: Contributions to intestinal homeostasis","volume":"32","author":"Zaki","year":"2011","journal-title":"Trends Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Qiang, R., Li, Y., Dai, X., and Lv, W. (2022). NLRP3 inflammasome in digestive diseases: From mechanism to therapy. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.978190"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jpeds.2010.02.024","article-title":"Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006","volume":"157","author":"Abramson","year":"2010","journal-title":"J Pediatr."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Demirtas Guner, D., Bildik, H.N., Demir, H., Cagdas, D., Saltik Temizel, I.N., Ozgul, R.K., Hizarcioglu Gulsen, H., Tan, C., Cicek, B., and Ozen, H. (2025). Genetic Variants in Early-Onset Inflammatory Bowel Disease: Monogenic Causes and Clinical Implications. Children, 12.","DOI":"10.3390\/children12050536"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1016\/j.cgh.2021.03.021","article-title":"A Systematic Review of Monogenic Inflammatory Bowel Disease","volume":"20","author":"Nambu","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"ii31","DOI":"10.1093\/ecco-jcc\/jjae087","article-title":"Considerations in Paediatric and Adolescent Inflammatory Bowel Disease","volume":"18","author":"Vuijk","year":"2024","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamapediatrics.2015.1982","article-title":"Inflammatory Bowel Disease in Children and Adolescents","volume":"169","author":"Rosen","year":"2015","journal-title":"JAMA Pediatr."},{"key":"ref_37","first-page":"88","article-title":"IBD across the age spectrum: Is it the same disease? Nature reviews","volume":"11","author":"Ruel","year":"2014","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5223\/pghn.2025.28.3.141","article-title":"Transitioning Pediatric Patients with Inflammatory Bowel Disease: Key Considerations for Adult Gastroenterologists","volume":"28","author":"Alwassief","year":"2025","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/apt.18264","article-title":"Differences in disease characteristics and treatment exposures between paediatric and adult-onset inflammatory bowel disease using a registry-based cohort","volume":"60","author":"Granot","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Ranson, N., Veldhuis, M., Mitchell, B., Fanning, S., Cook, A.L., Kunde, D., and Eri, R. (2019). NLRP3-Dependent and -Independent Processing of Interleukin (IL)-1\u03b2 in Active Ulcerative Colitis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20010057"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Zhang, G., Chen, H., Guo, Y., Zhang, W., Jiang, Q., Zhang, S., Han, L., Chen, S., and Xue, R. (2021). Activation of platelet NLRP3 inflammasome in crohn\u2019s disease. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.705325"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s10753-022-01647-8","article-title":"MEFV and NLRP3 inflammasome expression is attributed to immature macrophages and correlates with serum inflammatory proteins in Crohns disease patients","volume":"45","author":"Gorreja","year":"2022","journal-title":"Inflammation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.apsb.2021.03.011","article-title":"Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation","volume":"11","author":"Lv","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"44-Allen, I.C., TeKippe, E.M., Woodford, R.M., Uronis, J.M., Holl, E.K., Rogers, A.B., Herfarth, H.H., Jobin, C., and Ting, J.P.Y. (2010). The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med., 207, 1045\u20131056.","DOI":"10.1084\/jem.20100050"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Qu, S., Fan, L., Qi, Y., Xu, C., Hu, Y., Chen, S., Liu, W., Liu, W., and Si, J. (2021). Akkermansia muciniphila alleviates dextran sulfate sodium (DSS)-induced acute colitis by NLRP3 activation. Microbiol. Spectr., 9.","DOI":"10.1128\/Spectrum.00730-21"},{"key":"ref_46","first-page":"854","article-title":"Role of NLRP1 and NLRP3 inflammasome signaling pathways in the immune mechanism of inflammatory bowel disease in children","volume":"22","author":"Wang","year":"2020","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI98642","article-title":"Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn\u2019s disease","volume":"128","author":"Mao","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1073\/pnas.1813582116","article-title":"Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases","volume":"116","author":"Li","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1164\/ajrccm.161.3.9906013","article-title":"Bronchial hyperresponsiveness in children and adolescents with Crohn\u2019s disease","volume":"161","author":"Mansi","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.30526\/2021.IHICPAS.2645","article-title":"Gene Expression of NLRP3 Inflammasome in Celiac Disease of Iraqi Children","volume":"2021","author":"Ali","year":"2021","journal-title":"Ibn AL-Haitham J. Pure Appl. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathol-032520-024949","article-title":"The Spectrum of Helicobacter-Mediated Diseases","volume":"16","author":"Robinson","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cyto.2017.04.002","article-title":"Interleukin-18 protects mice from enterovirus 71 infection","volume":"96","author":"Li","year":"2017","journal-title":"Cytokine"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Abdul-Aziz, A.I. (2025). Molecular study and determining the levels of some interleukins in children with Entamoeba histolytica. Cytokine, 188.","DOI":"10.1016\/j.cyto.2025.156890"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Zhao, P., Li, J., Li, X., Dong, J., Wang, X., Zhang, N., Li, S., Sun, M., Zhang, X., and Wang, Z. (2023). The NLRP3 inflammasome recognizes alpha-2 and alpha-7.3 giardins and decreases the pathogenicity of Giardia duodenalis in mice. Parasites Vectors, 16.","DOI":"10.1186\/s13071-023-05688-2"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ni.2595","article-title":"Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function","volume":"14","author":"Sokolovska","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.cell.2015.10.072","article-title":"Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis","volume":"163","author":"Nowarski","year":"2015","journal-title":"Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.immuni.2015.03.004","article-title":"Distinct commensals induce interleukin-1b via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to injury","volume":"42","author":"Seo","year":"2015","journal-title":"Immunity"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1053\/j.gastro.2010.04.005","article-title":"Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome","volume":"139","author":"Ng","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.4049\/jimmunol.1400145","article-title":"Integrin-mediated first signal for inflammasome activation in intestinal epithelial cells","volume":"193","author":"Thinwa","year":"2014","journal-title":"J. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41575-018-0054-1","article-title":"Inflammasomes in the gastrointestinal tract: Infection, cancer and gut microbiota homeostasis","volume":"15","author":"Man","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.4049\/jimmunol.1601745","article-title":"Deletion of Nlrp3 Augments survival during polymicrobial sepsis by decreasing autophagy and enhancing phagocytosis","volume":"198","author":"Jin","year":"2017","journal-title":"J. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"De Jong, H.K., Koh, G.C., van Lieshout, M.H., Roelofs, J.J., van Dissel, J.T., van der Poll, T., and Wiersinga, W.J. (2014). Limited role for ASC and NLRP3 during in vivo Salmonella Typhimurium infection. BMC Immunol., 15.","DOI":"10.1186\/s12865-014-0030-7"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2020.05.048","article-title":"The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis","volume":"182","author":"Kitamoto","year":"2020","journal-title":"Cell"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Nguyen, J., Kotilea, K., Bontems, P., and Miendje Deyi, V.Y. (2023). Helicobacter pylori Infections in Children. Antibiotics, 12.","DOI":"10.3390\/antibiotics12091440"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1753425917738043","article-title":"Helicobacter pylori controls NLRP3 expression by regulating hsa-miR-223-3p and IL-10 in cultured and primary human immune cells","volume":"24","author":"Pachathundikandi","year":"2018","journal-title":"Innate Immun."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Pachathundikandi, S.K., Blaser, N., Bruns, H., and Backert, S. (2020). Helicobacter pylori avoids the critical activation of NLRP3 inflammasome-mediated production of oncogenic mature IL-1beta in human immune cells. Cancers, 12.","DOI":"10.3390\/cancers12040803"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Sinaei, R., Hosseininasab, A., Abbaslou, P., Zeinali, M., Iranmanesh, E., Sinaei, R., and Rahmanian, K. (2025). Gastrointestinal and hepatic manifestations among hospitalized COVID-19 children. BMC Pediatr., 25.","DOI":"10.1186\/s12887-025-05599-4"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Zhou, S., Lv, P., Li, M., Chen, Z., Xin, H., Reilly, S., and Zhang, X. (2023). SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development. Biomed. Pharmacother., 159.","DOI":"10.1016\/j.biopha.2023.114242"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Gordon, D.E., Hiatt, J., Bouhaddou, M., Rezelj, V.V., Ulferts, S., Braberg, H., Jureka, A.S., Obernier, K., Guo, J.Z., and Batra, J. (2020). Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science, 370.","DOI":"10.1126\/science.abe9403"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Nakra, N.A., Blumberg, D.A., Herrera-Guerra, A., and Lakshminrusimha, S. (2020). Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management. Children, 7.","DOI":"10.3390\/children7070069"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.15360\/1813-9779-2023-2-2304","article-title":"Inter-Alpha Inhibitor Proteins as a Predictor of Necrotizing Enterocolitis in Newborn Infants","volume":"19","author":"ELMeneza","year":"2023","journal-title":"Gen. Reanimatol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Yin, Y., Wang, J., Zhao, X., Wu, X., Zou, H., Qin, Z., and Cao, J. (2020). Overexpressed FOXO3 improves inflammatory status in mice by affecting NLRP3-mediated cell coronation in necrotizing colitis mice. Biomed. Pharmacother., 125.","DOI":"10.1016\/j.biopha.2020.109867"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Zhu, F., Wang, L., Gong, Z., Wang, Y., Gao, Y., Cai, W., and Wu, J. (2021). Blockage of NLRP3 inflammasome activation ameliorates acute inflammatory injury and long-term cognitive impairment induced by necrotizing enterocolitis in mice. J. Neuroinflamm., 18.","DOI":"10.1186\/s12974-021-02111-4"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Gryka-Marton, M., Grabowska, A.D., and Szukiewicz, D. (2025). Breaking the Barrier: The Role of Proinflammatory Cytokines in BBB Dysfunction. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26083532"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Shen, L., Zhong, X., Ji, H., Yang, S., Jin, J., Lyu, C., Ren, Y., Xiao, Y., Zhang, Y., and Fang, S. (2024). Macrophage \u03b17nAChR alleviates the inflammation of neonatal necrotizing enterocolitis through mTOR\/NLRP3\/IL-1\u03b2 pathway. Int. Immunopharmacol., 139.","DOI":"10.1016\/j.intimp.2024.112590"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"76. Chen, X., Long, R., Xu, F., Ye., W., and Li, N. (2025). The role of NLRP3 inflammasome in necrotizing enterocolitis. Pediatr. Res.","DOI":"10.1038\/s41390-025-04081-2"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Chen, J., Chen, T., Zhou, J., Zhao, X., Sheng, Q., and Lv, Z. (2021). MiR-146a-5p Mimic Inhibits NLRP3 Inflammasome Downstream Inflammatory Factors and CLIC4 in Neonatal Necrotizing Enterocolitis. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.594143"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.gtc.2020.01.010","article-title":"Hepatitis B: Immunization and Impact on Natural History and Cancer Incidence","volume":"49","author":"Lin","year":"2020","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/jmv.25490","article-title":"Hepatitis b core antigen can regulate NLRP3 inflammasome pathway in HepG2 cells","volume":"91","author":"Ding","year":"2019","journal-title":"J. Med. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Daussy, C.F., Monard, S.C., Guy, C., Mu\u00f1oz-Gonz\u00e1lez, S., Chazal, M., Anthonsen, M.W., Jouvenet, N., Henry, T., Dreux, M., and Meurs, E.F. (2021). The inflammasome components NLRP3 and ASC act in concert with IRGM to rearrange the golgi apparatus during hepatitis c virus infection. J. Virol., 95.","DOI":"10.1128\/JVI.00826-20"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.32114","article-title":"Hepatitis e virus infection activates NOD-like receptor family pyrin domain-containing 3 inflammasome antagonizing interferon response but therapeutically targetable","volume":"75","author":"Li","year":"2022","journal-title":"Hepatology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jare.2023.01.012","article-title":"Inflammasomes cross-talk with lymphocytes to connect the innate and adaptive immune response","volume":"54","author":"Zhang","year":"2023","journal-title":"J. Adv. Res."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Wang, H., Ma, L., Su, W., Liu, Y., Xie, N., and Liu, J. (2025). NLRP3 inflammasome in health and disease (Review). Int. J. Mol. Med., 55.","DOI":"10.3892\/ijmm.2025.5489"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Kasti, A., Katsas, K., Nikolaki, M.D., and Triantafyllou, K. (2025). The Role and the Regulation of NLRP3 Inflammasome in Irritable Bowel Syndrome: A Narrative Review. Microorganisms, 13.","DOI":"10.3390\/microorganisms13010171"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Speer, E.M., Diago-Navarro, E., Ozog, L.S., Raheel, M., Levy, O., and Fries, B.C. (2020). A Neonatal Murine Escherichia coli Sepsis Model Demonstrates That Adjunctive Pentoxifylline Enhances the Ratio of Anti- vs. Pro-inflammatory Cytokines in Blood and Organ Tissues. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.577878"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/SHK.0000000000001623","article-title":"Aluminum Adjuvant Improves Survival Via NLRP3 Inflammasome and Myeloid Non-Granulocytic Cells in a Murine Model of Neonatal Sepsis","volume":"55","author":"Rincon","year":"2021","journal-title":"Shock"},{"key":"ref_87","first-page":"501","article-title":"Nanobody-as versatile tool emerging in autoimmune diseases","volume":"5","author":"Wang","year":"2024","journal-title":"Smart Mater. Med."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Spano, M., Di Matteo, G., Ingallina, C., Ambroselli, D., Carradori, S., Gallorini, M., Giusti, A.M., Salvo, A., Grosso, M., and Mannina, L. (2022). Modulatory Properties of Food and Nutraceutical Components Targeting NLRP3 Inflammasome Activation. Nutrients, 14.","DOI":"10.3390\/nu14030490"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Li, H., Liu, T., Shi, X., Du, H., Cai, C., Yang, D., Qu, L., Dou, H., Jiao, B., and Jiao, B. (2025). Mechanisms and therapeutic potential of pharmacological agents targeting inflammasomes. Biomed. Pharmacother., 189.","DOI":"10.1016\/j.biopha.2025.118164"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Zheng, D., Liwinski, T., and Elinav, E. (2020). Inflammasome activation and regulation: Toward a better understanding of complex mechanisms. Cell Discov., 6.","DOI":"10.1038\/s41421-020-0167-x"}],"container-title":["Pediatric Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7503\/17\/5\/103\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:45:56Z","timestamp":1760071556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7503\/17\/5\/103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":90,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["pediatric17050103"],"URL":"https:\/\/doi.org\/10.3390\/pediatric17050103","relation":{},"ISSN":["2036-7503"],"issn-type":[{"type":"electronic","value":"2036-7503"}],"subject":[],"published":{"date-parts":[[2025,10,7]]}}}